Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) ...

Oppenheimer has upgraded Alcon (NYSE:ALC) to outperform ... approval of two enhancements for PanOptix IOL, a significant new capital upgrade cycle opportunity, and a market share opportunity ...

Notable recent launches from Alcon include PanOptix and Vivity, which were launched in the U.S. in 2019 and 2021, respectively. PanOptix is the first trifocal IOL approved by the FDA, and Vivity ...

Notable recent launches from Alcon include PanOptix and Vivity, which were launched in the U.S. in 2019 and 2021, respectively. PanOptix is the first trifocal IOL approved by the FDA, and Vivity ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity® , the most widely implanted9 extended depth of focus (EDOF) intraocular ...

The company’s flagship lenses, Vivity and PanOptix, continue to lead ... In Presbyopia-correcting Intraocular Lens (PCIOLs), Alcon currently leads the market with more than 60% of the global ...

CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales ... the UNITY VCS surgical platform, PanOptix Pro intraocular lens, and the Voyager laser trabeculoplasty device.

Alcon Inc (NYSE:ALC) is preparing to launch a rich product pipeline, including the Unity VCS faco device and PanOptix Pro PCIOL ... for advanced technology IOLs (ATIOL) faced competitive pressures ...

The company’s flagship lenses, Vivity and PanOptix, continue to lead the category in ... In Presbyopia-correcting Intraocular Lens (PCIOLs), Alcon currently leads the market with more than 60% of the ...